{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:50:46Z","timestamp":1777881046814,"version":"3.51.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Outstanding Youth Research Project of Jiangmen Central Hospital","award":["J202303"],"award-info":[{"award-number":["J202303"]}]},{"name":"Science and Technology Project of Guangdong Province","award":["22024A1515220140"],"award-info":[{"award-number":["22024A1515220140"]}]},{"name":"Science and Technology Project of Jiangmen","award":["2020030103110009027"],"award-info":[{"award-number":["2020030103110009027"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-15826-5","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T04:13:56Z","timestamp":1774325636000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of clinical, pathological and genomic characteristics between Lynch and non-Lynch patients with MMRd endometrial carcinoma"],"prefix":"10.1186","volume":"26","author":[{"given":"Haixin","family":"Mo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jihong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiadi","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueqing","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baoyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangliang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronggang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiufang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoning","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiongru","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taijin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingrong","family":"Qing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haicheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danyu","family":"Xian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nengtai","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"15826_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"key":"15826_CR2","doi-asserted-by":"publisher","unstructured":"Beyer S, et al. Expression of Intracellular Galectin-8 and -9 in Endometrial Cancer. Int J Mol Sci. 2024;25. https:\/\/doi.org\/10.3390\/ijms25136907.","DOI":"10.3390\/ijms25136907"},{"key":"15826_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nature12113","volume":"497","author":"Cancer Genome Atlas Research, N.","year":"2013","unstructured":"Cancer Genome Atlas Research, N., et al. Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497:67\u201373. https:\/\/doi.org\/10.1038\/nature12113.","journal-title":"Nature"},{"key":"15826_CR4","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/bjc.2015.190","volume":"113","author":"A Talhouk","year":"2015","unstructured":"Talhouk A, et al. A clinically applicable molecular-based classification for endometrial cancers. Br J Cancer. 2015;113:299\u2013310. https:\/\/doi.org\/10.1038\/bjc.2015.190.","journal-title":"Br J Cancer"},{"key":"15826_CR5","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/GCO.0000000000000508","volume":"31","author":"Z Chang","year":"2019","unstructured":"Chang Z, Talukdar S, Mullany SA, Winterhoff B. Molecular characterization of endometrial cancer and therapeutic implications. Curr Opin Obstet Gynecol. 2019;31:24\u201330. https:\/\/doi.org\/10.1097\/GCO.0000000000000508.","journal-title":"Curr Opin Obstet Gynecol"},{"key":"15826_CR6","doi-asserted-by":"publisher","unstructured":"Oaknin A, et al. Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient\/microsatellite instability-high (dMMR\/MSI-H) or proficient\/stable (MMRp\/MSS) endometrial cancer: interim results from GARNET-a phase I, single-arm study. J Immunother Cancer. 2022;10. https:\/\/doi.org\/10.1136\/jitc-2021-003777.","DOI":"10.1136\/jitc-2021-003777"},{"key":"15826_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.23750\/abm.v89i9-S.7960","volume":"89","author":"GL De' Angelis","year":"2018","unstructured":"De\u2019 Angelis GL, et al. Microsatellite instability in colorectal cancer. Acta Biomed. 2018;89:97\u2013101. https:\/\/doi.org\/10.23750\/abm.v89i9-S.7960.","journal-title":"Acta Biomed"},{"key":"15826_CR8","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.semcancer.2010.10.003","volume":"20","author":"ME Arana","year":"2010","unstructured":"Arana ME, Kunkel TA. Mutator phenotypes due to DNA replication infidelity. Semin Cancer Biol. 2010;20:304\u201311. https:\/\/doi.org\/10.1016\/j.semcancer.2010.10.003.","journal-title":"Semin Cancer Biol"},{"key":"15826_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.pharmthera.2018.04.004","volume":"189","author":"M Baretti","year":"2018","unstructured":"Baretti M, Le DT. DNA mismatch repair in cancer. Pharmacol Ther. 2018;189:45\u201362. https:\/\/doi.org\/10.1016\/j.pharmthera.2018.04.004.","journal-title":"Pharmacol Ther"},{"key":"15826_CR10","doi-asserted-by":"publisher","first-page":"1019798","DOI":"10.3389\/fonc.2022.1019798","volume":"12","author":"NG Reitsam","year":"2022","unstructured":"Reitsam NG, et al. Concurrent loss of MLH1, PMS2 and MSH6 immunoexpression in digestive system cancers indicating a widespread dysregulation in DNA repair processes. Front Oncol. 2022;12:1019798. https:\/\/doi.org\/10.3389\/fonc.2022.1019798.","journal-title":"Front Oncol"},{"key":"15826_CR11","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/nrc3399","volume":"12","author":"NJ Curtin","year":"2012","unstructured":"Curtin NJ. DNA repair dysregulation from cancer driver to therapeutic target. Nat Rev Cancer. 2012;12:801\u201317. https:\/\/doi.org\/10.1038\/nrc3399.","journal-title":"Nat Rev Cancer"},{"key":"15826_CR12","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nrm1907","volume":"7","author":"J Jiricny","year":"2006","unstructured":"Jiricny J. The multifaceted mismatch-repair system. Nat Rev Mol Cell Biol. 2006;7:335\u201346. https:\/\/doi.org\/10.1038\/nrm1907.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"15826_CR13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/cjp2.120","volume":"5","author":"AJ McCarthy","year":"2019","unstructured":"McCarthy AJ, et al. Heterogenous loss of mismatch repair (MMR) protein expression: a challenge for immunohistochemical interpretation and microsatellite instability (MSI) evaluation. J Pathol Clin Res. 2019;5:115\u201329. https:\/\/doi.org\/10.1002\/cjp2.120.","journal-title":"J Pathol Clin Res"},{"key":"15826_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/ijc.33763","volume":"150","author":"S Zhao","year":"2022","unstructured":"Zhao S, et al. Endometrial cancer in Lynch syndrome. Int J Cancer. 2022;150:7\u201317. https:\/\/doi.org\/10.1002\/ijc.33763.","journal-title":"Int J Cancer"},{"key":"15826_CR15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.19538\/j.fk2023010115","volume":"39","author":"G Zhang","year":"2023","unstructured":"Zhang G, et al. Chinese expert consensus on screening, prevention and treatment of endometrial carcinoma associated with Lynch syndrome (2023). Chin J Pract Gynecol Obstet. 2023;39:49\u201357. https:\/\/doi.org\/10.19538\/j.fk2023010115.","journal-title":"Chin J Pract Gynecol Obstet"},{"key":"15826_CR16","doi-asserted-by":"publisher","first-page":"107327482513426","DOI":"10.1177\/10732748251342685","volume":"32","author":"Y Zhi","year":"2025","unstructured":"Zhi Y, et al. M6A methylation regulators METTL3 and ALKBH5 are risk factors for EGFR-mutant NSCLC. Cancer Control. 2025;32:10732748251342684. https:\/\/doi.org\/10.1177\/10732748251342685.","journal-title":"Cancer Control"},{"key":"15826_CR17","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1200\/JCO.21.02506","volume":"40","author":"KW Thiel","year":"2022","unstructured":"Thiel KW, et al. TP53 sequencing and p53 immunohistochemistry predict outcomes when bevacizumab is added to frontline chemotherapy in endometrial cancer: an NRG oncology\/gynecologic oncology group study. J Clin Oncol. 2022;40:3289\u2013300. https:\/\/doi.org\/10.1200\/JCO.21.02506.","journal-title":"J Clin Oncol"},{"key":"15826_CR18","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/path.5375","volume":"250","author":"N Singh","year":"2020","unstructured":"Singh N, et al. p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies. J Pathol. 2020;250:336\u201345. https:\/\/doi.org\/10.1002\/path.5375.","journal-title":"J Pathol"},{"key":"15826_CR19","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.1002\/ijc.33115","volume":"147","author":"ME Salem","year":"2020","unstructured":"Salem ME, et al. Relationship between MLH1, PMS2, MSH2 and MSH6 gene-specific alterations and tumor mutational burden in 1057 microsatellite instability-high solid tumors. Int J Cancer. 2020;147:2948\u201356. https:\/\/doi.org\/10.1002\/ijc.33115.","journal-title":"Int J Cancer"},{"key":"15826_CR20","doi-asserted-by":"publisher","first-page":"155152","DOI":"10.1016\/j.prp.2024.155152","volume":"254","author":"N Kang","year":"2024","unstructured":"Kang N, et al. Validation of a one-step genomics-based molecular classifier for endometrial carcinoma in a large Chinese population. Pathol Res Pract. 2024;254:155152. https:\/\/doi.org\/10.1016\/j.prp.2024.155152.","journal-title":"Pathol Res Pract"},{"key":"15826_CR21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00428-020-03007-z","volume":"478","author":"N Concin","year":"2021","unstructured":"Concin N, et al. ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma. Virchows Arch. 2021;478:153\u201390. https:\/\/doi.org\/10.1007\/s00428-020-03007-z.","journal-title":"Virchows Arch"},{"key":"15826_CR22","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.19401\/j.cnki.1007-3639.2021.11.012","volume":"31","author":"The Society of Gynecological Cancer of China Anti-Cancer Association, C. S. o. P. o. t. C. M. A., National Pathology Quality Control Center","year":"2021","unstructured":"The Society of Gynecological Cancer of China Anti-Cancer Association, C. S. o. P. o. t. C. M. A., National Pathology Quality Control Center. The Chinese expert consensus recommendations on molecular testing in endometrial cancer (2021 edition). China Oncol. 2021;31:1126\u201344. https:\/\/doi.org\/10.19401\/j.cnki.1007-3639.2021.11.012.","journal-title":"China Oncol"},{"key":"15826_CR23","doi-asserted-by":"publisher","first-page":"e84453","DOI":"10.1371\/journal.pone.0084453","volume":"9","author":"I Hinrichsen","year":"2014","unstructured":"Hinrichsen I, et al. Promoter methylation of MLH1, PMS2, MSH2 and p16 is a phenomenon of advanced-stage HCCs. PLoS One. 2014;9:e84453. https:\/\/doi.org\/10.1371\/journal.pone.0084453.","journal-title":"PLoS One"},{"key":"15826_CR24","doi-asserted-by":"publisher","first-page":"551","DOI":"10.19401\/j.cnki.1007-3639.2020.07.011","volume":"30","author":"Y Zhu","year":"2020","unstructured":"Zhu Y. Chinese expert consensus on genomic testing of prostate cancer patients (the 2020 edition). China Oncol. 2020;30:551\u201360. https:\/\/doi.org\/10.19401\/j.cnki.1007-3639.2020.07.011.","journal-title":"China Oncol"},{"key":"15826_CR25","unstructured":"NCCN. Myelodysplastic syndromes. 2025."},{"key":"15826_CR26","unstructured":"NCCN. Genetic\/familial high-risk assessment: colorectal, endometrial, and gastric. 2024."},{"key":"15826_CR27","unstructured":"NCCN. Melanoma: cutaneous. 2025."},{"key":"15826_CR28","doi-asserted-by":"publisher","unstructured":"Joe S, et al. Enhanced Risk Stratification in Early-Stage Endometrial Cancer: Integrating POLE through Droplet Digital PCR and L1CAM. Cancers (Basel). 2023;15. https:\/\/doi.org\/10.3390\/cancers15194899.","DOI":"10.3390\/cancers15194899"},{"key":"15826_CR29","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.ygyno.2020.09.039","volume":"159","author":"C Carr","year":"2020","unstructured":"Carr C, et al. Clinicopathologic characteristics and outcomes of endometrial cancer patients with mismatch repair deficiency in the era of universal Lynch syndrome screening. Gynecol Oncol. 2020;159:712\u201320. https:\/\/doi.org\/10.1016\/j.ygyno.2020.09.039.","journal-title":"Gynecol Oncol"},{"key":"15826_CR30","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1001\/jamaoncol.2017.0619","volume":"3","author":"NAJ Ryan","year":"2017","unstructured":"Ryan NAJ, et al. Association of mismatch repair mutation with age at cancer onset in Lynch syndrome: implications for stratified surveillance strategies. JAMA Oncol. 2017;3:1702\u20136. https:\/\/doi.org\/10.1001\/jamaoncol.2017.0619.","journal-title":"JAMA Oncol"},{"key":"15826_CR31","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1136\/gutjnl-2015-309675","volume":"66","author":"P Moller","year":"2017","unstructured":"Moller P, et al. Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database. Gut. 2017;66:464\u201372. https:\/\/doi.org\/10.1136\/gutjnl-2015-309675.","journal-title":"Gut"},{"key":"15826_CR32","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1136\/ijgc-2019-000277","volume":"29","author":"G Bogani","year":"2019","unstructured":"Bogani G, et al. Impact of gene-specific germline pathogenic variants on presentation of endometrial cancer in Lynch syndrome. Int J Gynecol Cancer. 2019;29:705\u201310. https:\/\/doi.org\/10.1136\/ijgc-2019-000277.","journal-title":"Int J Gynecol Cancer"},{"key":"15826_CR33","doi-asserted-by":"publisher","unstructured":"Wilson CJ, Choy WY, Karttunen M. AlphaFold2: a role for disordered protein\/region prediction? Int J Mol Sci. 2022;23. https:\/\/doi.org\/10.3390\/ijms23094591.","DOI":"10.3390\/ijms23094591"},{"key":"15826_CR34","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41698-025-00803-1","volume":"9","author":"PJ Haight","year":"2025","unstructured":"Haight PJ, et al. Molecular characterization of mixed-histology endometrial carcinoma provides prognostic and therapeutic value over morphologic findings. NPJ Precis Oncol. 2025;9:41. https:\/\/doi.org\/10.1038\/s41698-025-00803-1.","journal-title":"NPJ Precis Oncol"},{"key":"15826_CR35","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1053\/j.gastro.2008.04.026","volume":"135","author":"L Senter","year":"2008","unstructured":"Senter L, et al. The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology. 2008;135:419\u201328. https:\/\/doi.org\/10.1053\/j.gastro.2008.04.026.","journal-title":"Gastroenterology"},{"key":"15826_CR36","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1200\/JCO.18.00283","volume":"37","author":"A Latham","year":"2019","unstructured":"Latham A, et al. Microsatellite instability is associated with the presence of Lynch syndrome pan-cancer. J Clin Oncol. 2019;37:286\u201395. https:\/\/doi.org\/10.1200\/JCO.18.00283.","journal-title":"J Clin Oncol"},{"key":"15826_CR37","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/cncr.27720","volume":"119","author":"KP Pennington","year":"2013","unstructured":"Pennington KP, et al. BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma. Cancer. 2013;119:332\u20138. https:\/\/doi.org\/10.1002\/cncr.27720.","journal-title":"Cancer"},{"key":"15826_CR38","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ygyno.2018.10.019","volume":"152","author":"B Long","year":"2019","unstructured":"Long B, et al. Cancer susceptibility gene mutations in type I and II endometrial cancer. Gynecol Oncol. 2019;152:20\u20135. https:\/\/doi.org\/10.1016\/j.ygyno.2018.10.019.","journal-title":"Gynecol Oncol"},{"key":"15826_CR39","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.trecan.2024.07.006","volume":"10","author":"S Spelier","year":"2024","unstructured":"Spelier S, Derksen S, Hofland R, Beekman JM, Yetkin-Arik B. CFTR and colorectal cancer susceptibility: an urgent need for further studies. Trends Cancer. 2024;10:876\u20139. https:\/\/doi.org\/10.1016\/j.trecan.2024.07.006.","journal-title":"Trends Cancer"},{"key":"15826_CR40","doi-asserted-by":"publisher","first-page":"15139","DOI":"10.1074\/jbc.271.25.15139","volume":"271","author":"FS Seibert","year":"1996","unstructured":"Seibert FS, et al. Disease-associated mutations in the fourth cytoplasmic loop of cystic fibrosis transmembrane conductance regulator compromise biosynthetic processing and chloride channel activity. J Biol Chem. 1996;271:15139\u201345. https:\/\/doi.org\/10.1074\/jbc.271.25.15139.","journal-title":"J Biol Chem"},{"key":"15826_CR41","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s10815-023-03010-8","volume":"41","author":"E Van Steijvoort","year":"2024","unstructured":"Van Steijvoort E, et al. Exploring attitudes and experiences with reproductive genetic carrier screening among couples seeking medically assisted reproduction: a longitudinal survey study. J Assist Reprod Genet. 2024;41:451\u201364. https:\/\/doi.org\/10.1007\/s10815-023-03010-8.","journal-title":"J Assist Reprod Genet"},{"key":"15826_CR42","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1513\/AnnalsATS.202201-024OC","volume":"20","author":"DB Salinas","year":"2023","unstructured":"Salinas DB, Wee CP, Bailey B, Raraigh K, Conrad D. Cystic fibrosis screen positive, inconclusive diagnosis genotypes in people with cystic fibrosis from the U.S. patient registry. Ann Am Thorac Soc. 2023;20:523\u201331. https:\/\/doi.org\/10.1513\/AnnalsATS.202201-024OC.","journal-title":"Ann Am Thorac Soc"},{"key":"15826_CR43","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1038\/s41467-025-57520-3","volume":"16","author":"X Yin","year":"2025","unstructured":"Yin X, et al. Pathogenic germline variants in Chinese pancreatic adenocarcinoma patients. Nat Commun. 2025;16:2214. https:\/\/doi.org\/10.1038\/s41467-025-57520-3.","journal-title":"Nat Commun"},{"key":"15826_CR44","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.molcel.2007.04.018","volume":"26","author":"JJ Warren","year":"2007","unstructured":"Warren JJ, et al. Structure of the human MutSalpha DNA lesion recognition complex. Mol Cell. 2007;26:579\u201392. https:\/\/doi.org\/10.1016\/j.molcel.2007.04.018.","journal-title":"Mol Cell"},{"key":"15826_CR45","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/s0022-2836(03)00694-6","volume":"331","author":"AW Kijas","year":"2003","unstructured":"Kijas AW, Studamire B, Alani E. Msh2 separation of function mutations confer defects in the initiation steps of mismatch repair. J Mol Biol. 2003;331:123\u201338. https:\/\/doi.org\/10.1016\/s0022-2836(03)00694-6.","journal-title":"J Mol Biol"},{"key":"15826_CR46","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40880-019-0388-2","volume":"39","author":"X Chao","year":"2019","unstructured":"Chao X, et al. Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China. Cancer Commun. 2019;39:42. https:\/\/doi.org\/10.1186\/s40880-019-0388-2.","journal-title":"Cancer Commun"},{"key":"15826_CR47","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jogc.2021.08.014","volume":"44","author":"G Turashvili","year":"2022","unstructured":"Turashvili G, Colgan T, McLachlin M, Lin H, Gharbharan R. Lynch syndrome screening of women with endometrial cancer: feasibility and outcomes in a community program. J Obstet Gynaecol Can. 2022;44:142\u20137. https:\/\/doi.org\/10.1016\/j.jogc.2021.08.014.","journal-title":"J Obstet Gynaecol Can"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15826-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15826-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15826-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:30:45Z","timestamp":1777595445000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15826-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15826"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15826-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Review Committee of Jiangmen Central Hospital (No: 2024\u201324). Written informed consent was obtained from all participants. All procedures were conducted in accordance with the principles outlined in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"548"}}